Mirae Asset Global Investments Co., Ltd. Exelixis, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$22.5 Billion
Q3 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Exelixis, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 10,317 shares of EXEL stock, worth $367,388. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,317

Previous 8,697 18.63%

Holding current value

$367,388

Previous $195,000 36.92%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$21.96 - $27.6 $35,575 - $44,712	1,620 Added 18.63%	10,317 $267,000
Q2 2024 Jul 30, 2024	SELL	$20.34 - $23.73 $550,685 - $642,466	-27,074 Reduced 75.69%	8,697 $195,000
Q1 2024 May 01, 2024	BUY	$20.17 - $23.93 $26,241 - $31,132	1,301 Added 3.77%	35,771 $848,000
Q4 2023 Jan 24, 2024	BUY	$19.25 - $24.13 $35,670 - $44,712	1,853 Added 5.68%	34,470 $826,000
Q3 2023 Oct 26, 2023	BUY	$19.04 - $22.74 $4,436 - $5,298	233 Added 0.72%	32,617 $712,000
Q2 2023 Aug 10, 2023	SELL	$18.17 - $20.48 $97,318 - $109,690	-5,356 Reduced 14.19%	32,384 $618,000
Q1 2023 May 04, 2023	BUY	$16.3 - $19.41 $324,647 - $386,588	19,917 Added 111.75%	37,740 $732,000
Q4 2022 Feb 09, 2023	BUY	$14.96 - $17.39 $5,984 - $6,956	400 Added 2.3%	17,823 $285,000
Q3 2022 Nov 10, 2022	SELL	$15.68 - $22.27 $39,027 - $55,430	-2,489 Reduced 12.5%	17,423 $273,000
Q2 2022 Jul 26, 2022	BUY	$17.44 - $23.16 $32,734 - $43,471	1,877 Added 10.41%	19,912 $414,000
Q1 2022 May 10, 2022	SELL	$17.03 - $22.67 $4,393 - $5,848	-258 Reduced 1.41%	18,035 $409,000
Q4 2021 Feb 08, 2022	BUY	$15.84 - $21.88 $2,027 - $2,800	128 Added 0.7%	18,293 $335,000
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $49,193 - $63,800	3,018 Added 19.92%	18,165 $384,000
Q2 2021 Aug 11, 2021	BUY	$17.95 - $25.56 $25,524 - $36,346	1,422 Added 10.36%	15,147 $276,000
Q1 2021 May 13, 2021	SELL	$20.53 - $25.22 $57,545 - $70,691	-2,803 Reduced 16.96%	13,725 $310,000
Q4 2020 Feb 10, 2021	BUY	$18.39 - $24.8 $11,567 - $15,599	629 Added 3.96%	16,528 $331,000
Q3 2020 Nov 12, 2020	BUY	$20.67 - $26.94 $127,368 - $166,004	6,162 Added 63.28%	15,899 $388,000
Q2 2020 Aug 11, 2020	BUY	$16.46 - $27.42 $160,271 - $266,988	9,737 New	9,737 $232,000

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Exelixis, Inc. Transaction History